According to the company, increased demand from customers in the pharmaceutical, food and cosmetic industries were the primary contributors for revenue growth during the period.
China Ruitai has posted a net income of $1.88m for the third quarter 2010, or $0.07 per diluted share, compared to a net income of $1.81m, or $0.07 per diluted share, for the comparable period in 2009.
The total revenue for the first nine months of fiscal 2010 was $32.6m, up 21.3% from $26.9m in the prior year’s period.
China Ruitai said that the revenues were driven by increased sales volumes of higher margin products complemented by sales to 93 pharmaceutical, food and cosmetics customers added year to date.
For the nine months ended 30 September 2010, China Ruitai posted a net income of $5.24m, or $0.20 per diluted share, compared to $4.39m, or $0.17 per diluted share, for the year ago period.
China Ruitai chairman Dianmin Ma said that they continued to increase the sell through to existing customers and add new ones, as evidenced by the EC contract they announced in October.